MELLONI, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 5.951
AS - Asia 2.258
EU - Europa 1.906
SA - Sud America 412
AF - Africa 43
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.576
Nazione #
US - Stati Uniti d'America 5.855
SG - Singapore 834
CN - Cina 707
IT - Italia 421
BR - Brasile 369
DE - Germania 360
HK - Hong Kong 265
PL - Polonia 262
UA - Ucraina 252
GB - Regno Unito 202
TR - Turchia 178
RU - Federazione Russa 93
VN - Vietnam 86
FI - Finlandia 85
SE - Svezia 69
ID - Indonesia 60
CA - Canada 53
FR - Francia 49
MX - Messico 34
IN - India 33
NL - Olanda 28
ZA - Sudafrica 24
BD - Bangladesh 21
ES - Italia 17
LT - Lituania 15
BE - Belgio 14
AR - Argentina 13
AT - Austria 13
JP - Giappone 13
CZ - Repubblica Ceca 9
IQ - Iraq 9
EC - Ecuador 8
PK - Pakistan 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
MA - Marocco 6
SA - Arabia Saudita 6
CL - Cile 5
DO - Repubblica Dominicana 5
PY - Paraguay 5
DZ - Algeria 4
EG - Egitto 4
RO - Romania 4
AU - Australia 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
BO - Bolivia 2
CI - Costa d'Avorio 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
KR - Corea 2
NP - Nepal 2
SR - Suriname 2
TW - Taiwan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CH - Svizzera 1
EU - Europa 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 10.576
Città #
Fairfield 708
Woodbridge 560
Ashburn 554
Houston 481
Singapore 409
Chandler 285
Seattle 276
Beijing 270
Santa Clara 269
Hong Kong 265
Jacksonville 264
Warsaw 258
Wilmington 247
Cambridge 237
Dallas 213
Ferrara 188
Ann Arbor 181
Izmir 109
Munich 109
Los Angeles 91
Nanjing 81
Princeton 72
New York 69
San Diego 64
Jakarta 56
Boardman 55
Milan 38
Shanghai 37
Falls Church 33
São Paulo 29
London 28
Mexico City 28
Buffalo 27
Shenyang 25
Chicago 24
Nanchang 23
Dong Ket 22
Turku 22
Hefei 21
Ho Chi Minh City 21
Dearborn 20
Bologna 19
San Mateo 19
The Dalles 19
Denver 18
Tianjin 18
Johannesburg 17
Brooklyn 16
Jiaxing 16
Poplar 16
Boston 15
Changsha 15
Montreal 15
Auburn Hills 14
Columbus 14
Frankfurt am Main 14
Hebei 14
Brussels 13
Rio de Janeiro 13
Stockholm 13
Atlanta 12
Bremen 12
Falkenstein 12
Hanoi 12
Montréal 12
Nuremberg 12
Orem 12
Mountain View 11
Norwalk 11
Tokyo 11
Chennai 10
Council Bluffs 10
Guangzhou 10
Jinan 10
Kunming 10
Moscow 10
San Francisco 10
Tappahannock 10
Toronto 10
Zhengzhou 10
Salt Lake City 9
Curitiba 8
Ferrara di Monte Baldo 8
Orange 8
Rome 8
Ankara 7
Des Moines 7
Elk Grove Village 7
Helsinki 7
Manchester 7
Tampa 7
Tashkent 7
Addison 6
Amsterdam 6
Aprilia 6
Belo Horizonte 6
Dhaka 6
Dronten 6
Guarulhos 6
Las Vegas 6
Totale 7.422
Nome #
Targeting mTOR in Acute Lymphoblastic Leukemia 251
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 242
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 227
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 213
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 212
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 206
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 203
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 194
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 193
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 188
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 183
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 182
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 178
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 176
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 174
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 173
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 169
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 169
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 167
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 166
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 163
Potential role of PKC inhibitors in the treatment of hematological malignancies 155
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 155
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 154
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 149
Eosinophils and purinergic signaling in health and disease 149
Role of CREB transcription factor in c-fos activation in natural killer cells. 148
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 140
In vitro apoptotic cell death during erythroid differentiation 140
Role of full-length osteoprotegerin in tumor cell biology. 137
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease 137
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 134
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 134
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 131
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 127
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 125
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 124
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 123
Selection and characterization of a novel agonistic human recombinant anti-Trail-R2 minibody with anti-leukemic activity 122
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 121
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway 119
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-α promote the NF-κB-dependent maturation of normal and leukemic myeloid cells 116
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. 114
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 112
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 110
TRICALCIUM PHOSPHATE STIMULATES ADIPOSE TISSUE-DERIVED STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 105
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 105
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 105
Colorectal cancer study with nanostructured sensors: Tumor marker screening of patient biopsies 104
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment 101
Role of vitamin D in the pathogenesis of atheromatosis 100
null 96
The response of human natural killer cells to interleukin-2. 94
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 92
null 92
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 92
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 90
null 90
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 90
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 90
null 89
null 88
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 86
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 86
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 85
null 84
null 83
Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. 83
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids 81
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 79
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 76
null 76
null 76
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 75
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 74
Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL 73
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage 69
null 69
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 67
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 65
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 64
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 62
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 61
MitoQ is able to modulate apoptosis and inflammation 57
Role of miRNA in adult ocular tumorigenesis 56
null 45
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 42
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 39
PEPTIDE-15 STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 38
Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol 31
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 24
null 15
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 8
Totale 10.757
Categoria #
all - tutte 52.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021914 0 0 0 0 111 157 73 134 44 187 130 78
2021/2022764 24 66 50 16 64 51 67 39 28 74 82 203
2022/2023716 83 38 31 78 102 109 39 56 90 7 47 36
2023/2024391 55 32 10 8 28 59 15 40 2 10 16 116
2024/20251.813 46 36 148 87 249 134 71 106 327 170 247 192
2025/20262.343 570 325 488 705 255 0 0 0 0 0 0 0
Totale 10.757